The scientific goal of the Cancer Control (CC) Program is to foster population-based research that will lead to a reduction in cancer morbidity and mortality in South Carolina (SC) while providing scientific evidence and novel cancer control interventions that can be applied beyond the state's borders. The CC Program investigators have made substantive progress toward this goal primarily through focused research efforts in two major themes - generating novel insights and approaches to tobacco control and addressing cancer health disparities. Within these two themes, the CC Program members work collaboratively to conduct and link research that identifies behavioral risk factors predisposing individuals to cancer development and to translate these findings into cost effective, sustainable interventions to modify risk factors. Furthermore, the CC Program members are working with government and community leaders to disseminate these evidence based strategies to impact the cancer burden in SC. Currently, the CC Program consists of 23 members representing 11 departments from within the College of Medicine, College of Nursing and the College of Pharmacy with more than $4.6M in peer-reviewed extramural research funding ($1.6M from the NCI) and another $640K in program-supportive training and career development awards. In the past five years, program members produced 170 publications with 17% of these representing inter-programmatic and 29% intra-programmatic collaborations, and 57% from multi-institutional collaborations.
The Hollings Cancer Center's Cancer Control Program conducts population-based research focused on reducing cancer morbidity and mortality in South Carolina while providing scientific evidence and novel cancer control interventions that can be applied beyond the state's borders.
|Song, J H; An, N; Chatterjee, S et al. (2015) Deletion of Pim kinases elevates the cellular levels of reactive oxygen species and sensitizes to K-Ras-induced cell killing. Oncogene 34:3728-36|
|Zemskova, Marina Y; Song, Jin H; Cen, Bo et al. (2015) Regulation of prostate stromal fibroblasts by the PIM1 protein kinase. Cell Signal 27:135-46|
|Boppana, Nithin B; Kodiha, Mohamed; Stochaj, Ursula et al. (2014) Ceramide synthase inhibitor fumonisin B1 inhibits apoptotic cell death in SCC17B human head and neck squamous carcinoma cells after Pc4 photosensitization. Photochem Photobiol Sci 13:1621-7|
|God, Jason M; Zhao, Dan; Cameron, Christine A et al. (2014) Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition. Immunology 142:492-505|
|Fuseler, John W; Robichaux, Jacqulyne P; Atiyah, Huda I et al. (2014) Morphometric and fractal dimension analysis identifies early neoplastic changes in mammary epithelium of MMTV-cNeu mice. Anticancer Res 34:1171-7|
|Esnaola, Nestor F; Chaudhary, Uzair B; O'Brien, Paul et al. (2014) Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 88:837-44|
|Chen, Weiqin; Zhou, Hongyi; Saha, Pradip et al. (2014) Molecular mechanisms underlying fasting modulated liver insulin sensitivity and metabolism in male lipodystrophic Bscl2/Seipin-deficient mice. Endocrinology 155:4215-25|
|Hussey, Sophie E; Lum, Helen; Alvarez, Andrea et al. (2014) A sustained increase in plasma NEFA upregulates the Toll-like receptor network in human muscle. Diabetologia 57:582-91|
|Kesarwani, Pravin; Al-Khami, Amir A; Scurti, Gina et al. (2014) Promoting thiol expression increases the durability of antitumor T-cell functions. Cancer Res 74:6036-47|
|He, Huacheng; Cattran, Alexander W; Nguyen, Tu et al. (2014) Triple-responsive expansile nanogel for tumor and mitochondria targeted photosensitizer delivery. Biomaterials 35:9546-53|
Showing the most recent 10 out of 162 publications